These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 224683)

  • 1. Differential susceptibility of peripheral nerves of the hen to triorthocresyl phosphate and to trauma.
    Krinke G; Ullmann L; Sachsse K; Hess R
    Agents Actions; 1979 Jun; 9(2):227-31. PubMed ID: 224683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A subchronic study (90 day) using multiple dose levels of tri-ortho-cresyl phosphate (TOCP): some neuropathological observations in the domestic hen.
    Prentice DE; Majeed SK
    Neurotoxicology; 1983; 4(2):277-82. PubMed ID: 6685267
    [No Abstract]   [Full Text] [Related]  

  • 3. Decreased phosphofructokinase activity during the development of triorthocresyl-phosphate-induced delayed neuropathy.
    Hernandez AF; Pla A; Villanueva E
    Toxicol Lett; 1989 Oct; 49(1):35-40. PubMed ID: 2554537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the delayed neurotoxicity of organophosphorus compounds--(III).
    Itoh H; Kishida H; Takeuchi E; Tadokoro M; Uchikoshi T; Oikawa K
    J Toxicol Sci; 1985 May; 10(2):67-82. PubMed ID: 2993636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metabolic inhibition with piperonyl butoxide on rodent sensitivity to tri-ortho-cresyl phosphate.
    Veronesi B
    Exp Neurol; 1984 Sep; 85(3):651-60. PubMed ID: 6088273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease of phosphofructokinase activity in relation to the pathogenesis of triorthocresyl-phosphate-induced delayed neuropathy.
    Hernández AF; Pla A; Villanueva E
    Rev Esp Fisiol; 1992 Sep; 48(3):139-46. PubMed ID: 1301629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease activity in brain, nerve, and muscle of hens given neuropathy-inducing organophosphates and a calcium channel blocker.
    el-Fawal HA; Correll L; Gay L; Ehrich M
    Toxicol Appl Pharmacol; 1990 Mar; 103(1):133-42. PubMed ID: 2156356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of delayed neurotoxicity in the mouse following chronic oral administration of tri-o-cresyl phosphate.
    Lapadula DM; Patton SE; Campbell GA; Abou-Donia MB
    Toxicol Appl Pharmacol; 1985 Jun; 79(1):83-90. PubMed ID: 4049409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rodent model of organophosphorus-induced delayed neuropathy: distribution of central (spinal cord) and peripheral nerve damage.
    Veronesi B
    Neuropathol Appl Neurobiol; 1984; 10(5):357-68. PubMed ID: 6521845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy in Tri-o-cresyl Phosphate-Induced Delayed Neurotoxicity.
    Xu HY; Wang P; Sun YJ; Jiang L; Xu MY; Wu YJ
    J Neuropathol Exp Neurol; 2017 Jan; 76(1):52-60. PubMed ID: 28040792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Toxicodynamic properties of liquids used for the cooling of high-power turbines. III. Neurotoxic effects].
    Florek E; Malendowicz L; Seńczuk W
    Med Pr; 1984; 35(1):1-6. PubMed ID: 6738345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Late neurologic consequence of triorthocresyl phosphate (TOCP)].
    Todorović S; Dordević S
    Vojnosanit Pregl; 1986; 43(2):124-7. PubMed ID: 3014734
    [No Abstract]   [Full Text] [Related]  

  • 13. Elevated intracellular Ca
    Song M; Kang K; Wang S; Zhang C; Zhao X; Song F
    Toxicology; 2024 May; 504():153812. PubMed ID: 38653376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylmethylsulfonyl fluoride protects against the degradation of neurofilaments in tri-ortho-cresyl phosphate (TOCP) induced delayed neuropathy.
    Song F; Yan Y; Zhao X; Dou D; Zhang C; Xie K
    Toxicology; 2009 Aug; 262(3):258-64. PubMed ID: 19573574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of drug metabolism inducers on the delayed neurotoxicity and disposition of tri-o-cresyl phosphate in hens following a single intravenous administration.
    Konno N; Katoh K; Yamauchi T; Fukushima M
    J Toxicol Sci; 1988 Feb; 13(1):17-30. PubMed ID: 3385808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anomalous phosphorylated neurofilament aggregations in central and peripheral axons of hens treated with tri-ortho-cresyl phosphate (TOCP).
    Jensen KF; Lapadula DM; Anderson JK; Haykal-Coates N; Abou-Donia MB
    J Neurosci Res; 1992 Nov; 33(3):455-60. PubMed ID: 1469747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic changes following treatment with organophosphorus-induced delayed neuropathy-producing agents in the adult hen.
    Robertson DG; Schwab BW; Sills RD; Richardson RJ; Anderson RJ
    Toxicol Appl Pharmacol; 1987 Mar; 87(3):420-9. PubMed ID: 3564017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electromyographic, neuropathologic, and functional correlates in the cat as the result of tri-o-cresyl phosphate delayed neurotoxicity.
    Abou-Donia MB; Trofatter LP; Graham DG; Lapadula DM
    Toxicol Appl Pharmacol; 1986 Mar; 83(1):126-41. PubMed ID: 3952742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of route of administration on the development of organophosphate-induced delayed neurotoxicity in 4-week-old chicks.
    Olson BA; Bursian SJ
    J Toxicol Environ Health; 1988; 23(4):499-505. PubMed ID: 3361617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity to tri-o-cresylphosphate neurotoxicity on n-hexane exposed hens as a model of simultaneous hexacarbon solvent and organophosphorus occupational intoxication.
    Pellín M; Vicedo JL; Vilanova E
    Arch Toxicol; 1987 Feb; 59(5):311-8. PubMed ID: 3579594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.